Salud

Asesoramiento crítico en su proceso

Los avances tecnológicos son cada vez mayores, lo que desafía el status quo en la industria de salud que está avanzando aceleradamente. Pero en una industria tan regulada, las alianzas estratégicas son la clave para el desarrollo de negocios. Nuestros asesores apasionados, apoyados por subsectores globalmente, utilizan su experiencia en M&A, renta variable de crecimiento y ECM, asesoría de deuda y finanzas corporativas para encontrar su lado competitivo, navegar costumbres locales y ayudarlo a crear la mejor estrategia posible.

Contacte al asesor

En todo el mundo

556

transacciones cerradas en Salud

En todo el mundo

Explore todas nuestras transacciones en la industria

Ir a las transacciones

Procaps S.A. has raised funds

Salud

Procaps S.A. has raised funds

Procaps S.A. has closed a club deal bank facility in a transaction financed by Bancolombia S.A. and Banco Davivienda S.A. The funds will be designated for the refinancing of existing debts owed to current creditors. This strategic allocation will empower the company to navigate its growth plan with enhanced financial strength.

Aprenda más

Procaps S.A. has completed a private placement of senior notes

Salud

Procaps S.A. has completed a private placement of senior notes

Procaps S.A. has raised funds to refinance existing debt with new institutional investors.

Aprenda más

Olyos Group has acquired a controlling stake in NewScience

Salud

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Aprenda más

“Oaklins’ efforts enabled us to join Banook and significantly enhance our impact on respiratory drug development. Together with an outstanding transaction team, we were able to efficiently integrate into the Banook platform, backed by Motion Equity Partners.”

Jan De Backer

CEO, Fluidda NV

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=CO&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Electronic medical device manufacturer secures buyer for two key subsidiaries in the US and Morocco

DEAL FLASH: Cicor Group has acquired the US and Moroccan subsidiaries of Valtronic. Through this transaction, Valtronic’s shareholders have secured the long-term development and success of the two entities, while Cicor gains access to the US market and doubles its production capacity in Morocco.

Aprenda más